NASDAQ:ABCO - The Advisory Board Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$53.8250 +0.05 (+0.09 %)
(As of 06/22/2018 04:56 AM ET)
Previous Close$53.8250
Today's Range$53.75 - $53.85
52-Week Range$30.40 - $59.50
Volume894,892 shs
Average Volume788,742 shs
Market Capitalization$2.19 billion
P/E RatioN/A
Dividend YieldN/A
The Advisory Board logoThe Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services. The best practices research and insight programs provide the foundation for all of its other programs. The Company offers technology analytics programs anchored by cloud-based software applications that surface performance improvement opportunities to accelerate progress. Through its consulting services, the Company provides on-the-ground support for performance improvement initiatives, as well as best practice professional management of areas of the hospital or medical group. The Company's data-enabled services are primarily focused in the area of enrollment management.

Receive ABCO News and Ratings via Email

Sign-up to receive the latest news and ratings for ABCO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryResearch & Consulting Services


Debt-to-Equity Ratio0.98
Current Ratio1.07
Quick Ratio1.07


Trailing P/E RatioN/A
Forward P/E Ratio35.88
P/E Growth2.4

Sales & Book Value

Annual Sales$803.42 million
Price / Sales2.73
Cash Flow$3.7535 per share
Price / Cash14.34
Book Value$12.88 per share
Price / Book4.18


EPS (Most Recent Fiscal Year)N/A
Net Income$91.23 million
Net Margins-3.42%
Return on Equity0.48%
Return on Assets-1.23%


Outstanding Shares40,760,000

The Advisory Board (NASDAQ:ABCO) Frequently Asked Questions

What is The Advisory Board's stock symbol?

The Advisory Board trades on the NASDAQ under the ticker symbol "ABCO."

How were The Advisory Board's earnings last quarter?

The Advisory Board Company (NASDAQ:ABCO) released its quarterly earnings results on Wednesday, July, 27th. The business services provider reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.34 by $0.13. The business services provider had revenue of $198.40 million for the quarter, compared to analysts' expectations of $196.49 million. The Advisory Board had a positive return on equity of 0.48% and a negative net margin of 3.42%. The firm's revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.40 earnings per share. View The Advisory Board's Earnings History.

What price target have analysts set for ABCO?

9 brokerages have issued 1 year target prices for The Advisory Board's shares. Their predictions range from $51.00 to $56.00. On average, they expect The Advisory Board's stock price to reach $53.7557 in the next twelve months. View Analyst Ratings for The Advisory Board.

Who are The Advisory Board's key executives?

The Advisory Board's management team includes the folowing people:
  • Robert W. Musslewhite J.D., Chairman of the Board, Chief Executive Officer (Age 47)
  • David L. Felsenthal, President, Director (Age 46)
  • Michael T. Kirshbaum, Chief Financial Officer, Treasurer (Age 40)
  • Richard A. Schwartz Ph.D., Chief Operating Officer - Health Care (Age 51)
  • Cormac F. Miller, Chief Product Officer (Age 43)
  • Mary D. Van Hoose, Chief Talent Officer (Age 52)
  • Evan R. Farber, Chief Legal Officer and Corporate Secretary (Age 44)
  • Kelt Kindick, Lead Independent Director (Age 62)
  • Sanjeev K. Bansal, Independent Director (Age 51)
  • Peter J. Grua, Independent Director (Age 63)

Has The Advisory Board been receiving favorable news coverage?

News coverage about ABCO stock has trended positive recently, according to Accern. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. The Advisory Board earned a news sentiment score of 0.31 on Accern's scale. They also gave news coverage about the business services provider an impact score of 45.44 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of The Advisory Board?

Shares of ABCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is The Advisory Board's stock price today?

One share of ABCO stock can currently be purchased for approximately $53.8250.

How big of a company is The Advisory Board?

The Advisory Board has a market capitalization of $2.19 billion and generates $803.42 million in revenue each year. The Advisory Board employs 3,800 workers across the globe.

How can I contact The Advisory Board?

The Advisory Board's mailing address is 2445 M St NW, WASHINGTON, DC 20037-1435, United States. The business services provider can be reached via phone at +1-202-2665600 or via email at [email protected]

MarketBeat Community Rating for The Advisory Board (ABCO)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  348 (Vote Outperform)
Underperform Votes:  295 (Vote Underperform)
Total Votes:  643
MarketBeat's community ratings are surveys of what our community members think about The Advisory Board and other stocks. Vote "Outperform" if you believe ABCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.